Keiji Kubo

2.3k total citations
49 papers, 1.9k citations indexed

About

Keiji Kubo is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Keiji Kubo has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 13 papers in Molecular Biology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Keiji Kubo's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Synthesis and biological activity (7 papers) and Renin-Angiotensin System Studies (5 papers). Keiji Kubo is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Synthesis and biological activity (7 papers) and Renin-Angiotensin System Studies (5 papers). Keiji Kubo collaborates with scholars based in Japan, United States and Germany. Keiji Kubo's co-authors include Takehiko Naka, Yasuhisa Kohara, Takeo Wada, Yoshiyuki Inada, Kohei Nishikawa, Eiko Imamiya, Tsukasa Sanada, Yumiko Shibouta, Mami Ojima and Yoshiyasu Furukawa and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

Keiji Kubo

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keiji Kubo Japan	19	645	609	553	326	268	49	1.9k
Gisele Zapata‐Sudo Brazil	29	413 0.6×	685 1.1×	411 0.7×	209 0.6×	284 1.1×	107	2.1k
Toichi Takenaka Japan	25	356 0.6×	781 1.3×	237 0.4×	176 0.5×	208 0.8×	106	1.8k
Anna Hsu United States	25	276 0.4×	1.4k 2.3×	169 0.3×	123 0.4×	107 0.4×	46	2.5k
Wolfgang Wienen Germany	28	2.3k 3.5×	1.1k 1.8×	408 0.7×	424 1.3×	438 1.6×	48	4.2k
Kohei Nishikawa Japan	28	1.1k 1.7×	990 1.6×	447 0.8×	509 1.6×	240 0.9×	118	3.3k
Kou‐Yi Tserng United States	27	219 0.3×	1.1k 1.9×	158 0.3×	202 0.6×	172 0.6×	74	2.4k
Scott Grossman United States	25	372 0.6×	442 0.7×	131 0.2×	101 0.3×	169 0.6×	58	1.8k
Toshimi Kanbe Japan	18	174 0.3×	249 0.4×	197 0.4×	52 0.2×	243 0.9×	38	1.0k
Nicholas S. Kirkby United Kingdom	26	714 1.1×	617 1.0×	101 0.2×	129 0.4×	280 1.0×	72	2.4k
C. Picard France	11	728 1.1×	261 0.4×	165 0.3×	173 0.5×	264 1.0×	20	1.3k

Countries citing papers authored by Keiji Kubo

Since Specialization

Citations

This map shows the geographic impact of Keiji Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Kubo more than expected).

Fields of papers citing papers by Keiji Kubo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiji Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Kubo. The network helps show where Keiji Kubo may publish in the future.

Co-authorship network of co-authors of Keiji Kubo

This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Kubo. A scholar is included among the top collaborators of Keiji Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Kubo. Keiji Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imaeda, Yasuhiro, Michiko Tawada, Mitsuyo Kondo, et al.. (2016). Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 5771–5780. 11 indexed citations

Kubo, Keiji, et al.. (2015). Efficacy of pre-operative computed tomography evaluation of the tympanic cavity for hearing improvement after stapes surgery for tympanosclerosis with stapes fixation. The Journal of Laryngology & Otology. 129(S2). S27–S32. 4 indexed citations

Kawamura, Masaki, et al.. (2010). Antithrombotic and Anticoagulant Profiles of TAK-442, a Novel Factor Xa Inhibitor, in a Rabbit Model of Venous Thrombosis. Journal of Cardiovascular Pharmacology. 56(2). 156–161. 10 indexed citations

Imaeda, Yasuhiro, Hiroki Sakamoto, Fumio Itoh, et al.. (2007). Discovery of sulfonylalkylamides: A new class of orally active factor Xa inhibitors. Bioorganic & Medicinal Chemistry. 16(5). 2243–2260. 12 indexed citations

Kubo, Keiji, et al.. (2004). Implant surgery for a patient with Parkinson's disease controlled by intravenous midazolam: a case report.. PubMed. 19(2). 288–90. 14 indexed citations

Fujimoto, Keisaku, Shinji Yamaguchi, Keiji Kubo, et al.. (2003). Evaluation of the Number of Inhalations in Fultide Required by Patients Based on the Findings of Pulmonary Function Tests. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29(2). 155–158. 1 indexed citations

Fujimoto, Keisaku, Shinji Yamaguchi, Keiji Kubo, et al.. (2002). Patient Monitoring for Proper Use of Flutide. First Report: Evaluation of Operation and Investigation of Patients Satisfaction with the Diskhaler.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(4). 347–352.

Hori, Akira, Yasuhiro Imaeda, Keiji Kubo, & Masami Kusaka. (2002). Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo. Cancer Letters. 183(1). 53–60. 27 indexed citations

Ojima, Mami, Yoshiyuki Inada, Yumiko Shibouta, et al.. (1997). Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor. European Journal of Pharmacology. 319(1). 137–146. 122 indexed citations

10.

Nishikawa, Kohei, Takehiko Naka, Masakuni Noda, et al.. (1996). Angiotensin II receptor antagonistic action of candesartan (CV-11974) in the rabbit aorta. 24(10). 121–126. 2 indexed citations

11.

Kohara, Yasuhisa, Eiko Imamiya, Keiji Kubo, et al.. (1995). A new class of angiotensin II receptor antagonists with a novel acidic bioisostere. Bioorganic & Medicinal Chemistry Letters. 5(17). 1903–1908. 41 indexed citations

12.

Naka, Takehiko, Keiji Kubo, & Yoshiyasu Furukawa. (1995). Non-peptide Angiotensin II Receptor Antagonists.. Journal of Synthetic Organic Chemistry Japan. 53(9). 802–810. 33 indexed citations

13.

Inada, Yoshiyuki, et al.. (1993). Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Biochemical Pharmacology. 46(2). 311–318. 126 indexed citations

14.

Kubo, Keiji, Yasuhisa Kohara, Eiko Imamiya, et al.. (1993). Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids. Journal of Medicinal Chemistry. 36(15). 2182–2195. 117 indexed citations

15.

Shibouta, Yumiko, Yasuhiro Inada, M Ojima, et al.. (1993). Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).. Journal of Pharmacology and Experimental Therapeutics. 266(1). 114–120. 200 indexed citations

16.

Kubo, Keiji, Yoshiyuki Inada, Yasuhisa Kohara, et al.. (1993). Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles. Journal of Medicinal Chemistry. 36(12). 1772–1784. 111 indexed citations

17.

Adachi, Masahiro, et al.. (1992). SEIZURE-LIKE MOVEMENTS DURING INDUCTION OF ANAESTHESIA WITH SEVOFLURANE. British Journal of Anaesthesia. 68(2). 214–215. 96 indexed citations

18.

Lorenz, W., Keiji Kubo, B. Stinner, et al.. (1992). Studies on the effectiveness of H1-+H2-antagonist combinations in preventing life-threatening anaphylactoid reactions in anaesthesia and surgery: Problems with selecting the animal model from clinical data and with “equi-effective” doses. Inflammation Research. 36(S2). C231–C237. 3 indexed citations

19.

Sattler, J., et al.. (1989). Food-induced histaminosis under diamine oxidase (DAO) blockade in pigs: Further evidence of the key role of elevated plasma histamine levels as demonstrated by successful prophylaxis with antihistamines. Inflammation Research. 27(1-2). 212–214. 26 indexed citations

20.

Kubo, Keiji, et al.. (1986). Synthesis of (3-carboxy-5-oxo-5H-(1)benzopyrano(2,3-b)pyridin-2-yl)acetic acid derivatives, potential antiarthritic agents.. Chemical and Pharmaceutical Bulletin. 34(3). 1108–1117. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact